Scientific article
English

Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant

Published inExpert opinion on pharmacotherapy, vol. 15, no. 7, p. 953-959
Publication date2014
Abstract

Diabetic macular edema (DME) can be treated with intravitreal glucocorticoids, particularly triamcinolone acetonide, dexamethasone (DEX), and fluocinolone acetonide (FA).

Keywords
  • Animals
  • Delayed-Action Preparations/chemistry
  • Dexamethasone/administration & dosage/therapeutic use
  • Diabetic Retinopathy/complications/drug therapy
  • Drug Implants/administration & dosage/therapeutic use
  • Fluocinolone Acetonide/administration & dosage/therapeutic use
  • Glucocorticoids/administration & dosage/therapeutic use
  • Humans
  • Intravitreal Injections
  • Macular Edema/complications/drug therapy
  • Triamcinolone Acetonide/administration & dosage/therapeutic use
Citation (ISO format)
CIULLA, Thomas A et al. Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant. In: Expert opinion on pharmacotherapy, 2014, vol. 15, n° 7, p. 953–959. doi: 10.1517/14656566.2014.896899
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
Journal ISSN1465-6566
493views
0downloads

Technical informations

Creation30/11/2016 09:27:00
First validation30/11/2016 09:27:00
Update15/03/2023 01:11:21
Status update15/03/2023 01:11:21
Last indexation31/10/2024 05:38:21
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack